The Cary, North Carolina-based analytic software firm says the new version of its Drug Development 3.0 solution comes packed with a range of analytic and collaborative features designed to streamline the clinic trial lifecycle. The solution is on top of the SAS 9 Intelligence Platform and can be deployed in either standalone or hosted mode.
Speeding up clinical research for regulatory submission is a critical differentiator for life sciences firms. Even small delays can potentially result in millions of lost dollars. SAS life sciences customers include Merck & Co, Solvay Pharmaceuticals, NeoPhram and Sankyo.
Content from our partners
